LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.56234
 16.00 771.67 1440 1585 0.9082 0.8230
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 18.22 771.67 1356 1741 0.7787 0.6163
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 18.22 771.67 1437 1741 0.8252 0.6981
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 20.44 771.67 1413 1910 0.7395 0.5879
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 20.44 771.67 1475 1910 0.7719 0.6409
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 22.66 771.67 1518 2141 0.7089 0.5832
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 22.66 771.67 1544 2141 0.7210 0.6016
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 24.89 771.67 1605 2397 0.6694 0.5648
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 24.89 771.67 1628 2397 0.6790 0.5784
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 27.11 771.67 1712 2675 0.6400 0.5594
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 27.11 771.67 1648 2675 0.6161 0.5266
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 29.33 771.67 1825 2939 0.6209 0.5623
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 29.33 771.67 1737 2939 0.5909 0.5227
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 31.55 771.67 1944 3196 0.6081 0.5692
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 31.55 771.67 1810 3196 0.5662 0.5155
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 33.78 771.67 2038 3499 0.5824 0.5609
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 33.78 771.67 1903 3499 0.5438 0.5126
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 36.00 771.67 2190 3884 0.5637 0.5642
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 36.00 771.67 2025 3884 0.5213 0.5125
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 38.22 771.67 2311 4299 0.5375 0.5568
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 38.22 771.67 2087 4299 0.4854 0.4940
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 40.44 771.67 2406 4738 0.5078 0.5439
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 40.44 771.67 2204 4738 0.4651 0.4930
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 42.67 771.67 2524 5155 0.4896 0.5411
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 42.67 771.67 2326 5155 0.4512 0.4958
MN20160304_L01
L15